Have your own idea? Try our Stock Screener
Norwegian (OSEAX) Pharma Industry Analysis
UpdatedDec 15, 2025
DataAggregated Company Financials
Companies5
- 7D1.7%
- 3M2.9%
- 1Y5.9%
- YTD-4.8%
The Pharma industry is up 1.7% in the last week, with Navamedic up 17%. During this same period, the Oncoinvent underperformed, falling 14%. This takes the industry's 12 month performance to a gain of 5.7%. As for the next few years, earnings are expected to grow by 131% per annum.
Industry Valuation and Performance
Has the Norwegian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 15 Dec 2025 | NOK 3.7b | NOK 1.6b | -NOK 67,438,434.00 | 427.3x | -54.3x | 2.3x |
| Wed, 12 Nov 2025 | NOK 3.3b | NOK 1.6b | -NOK 79,791,434.00 | 363.9x | -41.3x | 2.1x |
| Fri, 10 Oct 2025 | NOK 3.1b | NOK 1.5b | -NOK 83,687,434.00 | 13.5x | -37.5x | 2.1x |
| Sun, 07 Sep 2025 | NOK 3.5b | NOK 1.5b | -NOK 87,981,434.00 | 13.6x | -39.4x | 2.3x |
| Tue, 05 Aug 2025 | NOK 3.6b | NOK 1.5b | -NOK 99,242,434.00 | 14x | -36.1x | 2.4x |
| Thu, 03 Jul 2025 | NOK 3.4b | NOK 1.5b | -NOK 91,864,434.00 | 351.8x | -37.2x | 2.2x |
| Sat, 31 May 2025 | NOK 3.3b | NOK 1.5b | -NOK 122,678,000.00 | 319.9x | -26.6x | 2.1x |
| Mon, 28 Apr 2025 | NOK 3.3b | NOK 1.5b | -NOK 115,916,000.00 | 152.7x | -28.8x | 2.2x |
| Wed, 26 Mar 2025 | NOK 3.4b | NOK 1.5b | -NOK 153,695,743.00 | 164.8x | -21.8x | 2.2x |
| Fri, 21 Feb 2025 | NOK 3.1b | NOK 1.5b | -NOK 13,494,743.00 | 157.6x | -227.8x | 2.1x |
| Sun, 19 Jan 2025 | NOK 2.9b | NOK 1.5b | NOK 22.4m | 23x | 131x | 2x |
| Tue, 17 Dec 2024 | NOK 3.1b | NOK 1.5b | NOK 22.4m | 24.4x | 138.1x | 2.1x |
| Thu, 14 Nov 2024 | NOK 3.0b | NOK 1.5b | NOK 33.3m | 21.6x | 89.5x | 2x |
| Sat, 12 Oct 2024 | NOK 3.2b | NOK 1.5b | NOK 45.2m | 22.3x | 70.4x | 2.1x |
| Mon, 09 Sep 2024 | NOK 2.9b | NOK 1.5b | NOK 105.8m | 19.6x | 27.5x | 1.9x |
| Wed, 07 Aug 2024 | NOK 2.8b | NOK 1.5b | NOK 49.7m | 149.2x | 56.9x | 1.9x |
| Fri, 05 Jul 2024 | NOK 3.1b | NOK 1.5b | NOK 49.7m | 172.7x | 63.2x | 2.1x |
| Sun, 02 Jun 2024 | NOK 3.4b | NOK 1.5b | NOK 7.6m | 193x | 447.6x | 2.3x |
| Tue, 30 Apr 2024 | NOK 3.3b | NOK 1.5b | NOK 18.3m | 153.6x | 178.8x | 2.2x |
| Thu, 28 Mar 2024 | NOK 3.1b | NOK 1.5b | NOK 7.6m | 162.7x | 406.3x | 2.1x |
| Sat, 24 Feb 2024 | NOK 3.1b | NOK 1.5b | NOK 33.1m | 167x | 94.4x | 2.1x |
| Mon, 22 Jan 2024 | NOK 3.6b | NOK 1.4b | NOK 18.6m | 25.9x | 194.5x | 2.5x |
| Wed, 20 Dec 2023 | NOK 3.5b | NOK 1.4b | NOK 18.6m | 25.4x | 188.2x | 2.5x |
| Fri, 17 Nov 2023 | NOK 3.1b | NOK 1.4b | NOK 18.6m | 24.2x | 167.5x | 2.2x |
| Sun, 15 Oct 2023 | NOK 3.5b | NOK 1.3b | -NOK 38,433,125.00 | 53.8x | -90x | 2.6x |
| Tue, 12 Sep 2023 | NOK 2.8b | NOK 1.3b | -NOK 53,836,125.00 | 48x | -52.1x | 2.1x |
| Thu, 10 Aug 2023 | NOK 2.9b | NOK 1.2b | -NOK 60,357,125.00 | 74.9x | -48.4x | 2.3x |
| Sat, 08 Jul 2023 | NOK 3.0b | NOK 1.2b | -NOK 60,357,125.00 | 75.7x | -50.2x | 2.4x |
| Mon, 05 Jun 2023 | NOK 3.2b | NOK 1.2b | -NOK 104,503,000.00 | 79.8x | -30.2x | 2.6x |
| Wed, 03 May 2023 | NOK 3.1b | NOK 1.1b | -NOK 140,813,000.00 | 21.1x | -22.2x | 2.9x |
| Fri, 31 Mar 2023 | NOK 3.1b | NOK 1.1b | -NOK 140,813,000.00 | 23.2x | -22x | 2.8x |
| Sun, 26 Feb 2023 | NOK 3.9b | NOK 1.1b | -NOK 140,813,000.00 | 21.4x | -27.3x | 3.5x |
| Tue, 24 Jan 2023 | NOK 4.6b | NOK 1.0b | -NOK 148,546,289.00 | 44.8x | -31x | 4.5x |
| Thu, 22 Dec 2022 | NOK 4.5b | NOK 1.0b | -NOK 148,546,289.00 | 47.3x | -30.1x | 4.4x |
Price to Earnings Ratio
-30.1x
Current Industry PE
- Investors are relatively neutral on the Norwegian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 15% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Norwegian Healthcare industry?
| NO Market | 0.17% | |
| Healthcare | 0.67% | |
| Pharma | 1.71% | |
| Pharma | 1.71% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NAVA Navamedic | NOK 25.20 | 15.1% +NOK 79.1m | -7.0% | PS1.1x | |
| PHO Photocure | NOK 67.10 | 1.5% +NOK 26.6m | 18.8% | PE842.9x |